Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancer

Trial Profile

Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Carperitide (Primary)
  • Indications Acute heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Jul 2017 Planned number of patients changed from 5 to 6.
    • 06 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top